DNAnexus customers now have a choice of two cloud platforms and ancillary tools and the company has access to a wider pool of potential users.
Researchers participating in ORIEN's Avatar program can use the platform to manage, share, integrate, and analyze molecular data from consenting patients.
The current arrangement builds on an existing agreement signed last year that allowed Garvan to use DNAnexus' platform for its genomics activities.
The WGS service will be provided by Genome.One, a new health information company owned by and based at the Garvan Institute of Medical Research in Sydney.
The combined solution gives customers access to the bioinformatics tools and genomic intelligence to help them analyze data and make business decisions.
The tools the partners plan to develop will help researchers optimize genomic analysis workflows and better identify links between genes and disease.
In a JNCCN paper, the investigators discussed their efforts to comprehensively characterize a single patient's breast tumor and test potential treatments.
Under the terms of the agreement, DNAnexus will make Sapio's LIMS software available on its genomics infrastructure.
The FDA established the platform to allow scientists to test their NGS assays and to advance the regulatory science for assessing genomic tests and software.
The companies have signed an agreement to integrate Qiagen's variant interpretation solution with DNAnexus' cloud-based platform.
A fire at a Manchester hospital may have destroyed lab equipment and data, the Guardian reports.
Researchers generate a genetic database from skeletal remains from the 1845 Franklin Expedition to the Arctic, Live Science reports.
Researchers in China have begun another trial using CRISPR/Cas9 approaches in cancer patients, according to the Wall Street Journal.
In Science this week: human DNA found in sediments from archeological sites lacking bones, and more.